Provided by Tiger Trade Technology Pte. Ltd.

Neurosense Therapeutics Ltd

4.43
-0.3500-7.32%
Post-market: 4.430.00000.00%19:55 EDT
Volume:40.38K
Turnover:178.14K
Market Cap:8.37M
PE:-0.51
High:4.74
Open:4.71
Low:4.00
Close:4.78
52wk High:26.64
52wk Low:4.00
Shares:1.89M
Float Shares:1.29M
Volume Ratio:1.63
T/O Rate:3.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.7319
EPS(LYR):-8.7319
ROE:-2174.98%
ROA:-247.30%
PB:-5.36
PE(LYR):-0.51

Loading ...

Aug 14, 2023

Correspondence

Form CORRESP - Correspondence
Jul 21, 2023

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Apr 05, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 22, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 15, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2023

Correspondence

CORRESP [Cover] - Correspondence
Apr 14, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 02, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 30, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 23, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Dec 06, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 19, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Nov 10, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers